Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SStoke Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

Stoke Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Habent enim et bene longam et satis
    Jul 22, 2021Stoke Therapeutics
  • Cuius quidem, quoniam Stoicus fuit
    Jul 22, 2021Stoke Therapeutics
  • Intellegi quidem, ut propter aliam quampiam rem
    Jul 22, 2021Stoke Therapeutics
  • Hic ambiguo ludimur. Quem Tiberina
    Jul 22, 2021Stoke Therapeutics
  • Hosne igitur laudas et hanc eorum, inquam
    Jul 22, 2021Stoke Therapeutics
  • Duo Reges: constructio interrete. Si enim, ut mihi
    Jul 22, 2021Stoke Therapeutics
  • Tecum optime, deinde etiam cum mediocri amico
    Jul 22, 2021Stoke Therapeutics
  • Morbo gravissimo affectus, exul, orbus, egens
    Jul 22, 2021Stoke Therapeutics
  • Qui enim voluptatem ipsam contemnunt, iis
    Jul 22, 2021Stoke Therapeutics
  • Bona autem corporis huic sunt, quod posterius posui
    Jul 22, 2021Stoke Therapeutics
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions